Ian Kimbrough, an assistant professor in the School of Neuroscience, and Jennifer Munson, an assistant professor in the Department of Biomedical Engineering and Mechanics, are taking research learned from brain tumors to help fight Alzheimer’s.
Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer.
The same brain cells designed to stop brain damage fail to support healthy neurons when a cancer grows. New research, led by Stefanie Robel and Harald Sontheimer at the Fralin Biomedical Research Institute at VTC, reveals how gliomas alter astrocytes, a cell type that helps protect neurons and is crucial to preventing seizures.
Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.
The program is based on the Virginia Tech Carilion Health Sciences and Technology Campus in Roanoke, and it positions students to conduct research in more than 50 departments and institutes across Virginia Tech.
Students and alumni nominated individuals who provided clear expectations and high standards for students to conduct original hypothesis-driven research effectively and provide opportunities for professional growth.
A relatively unexplored area of cancer research, interstitial fluid flow, or the movement of fluid around and through the three-dimensional space surrounding cells, has been shown to lead to an increase in cancer cell invasion. However, the mechanisms of how and why that happens, particularly in cases of brain cancer, are still unknown.
Acomhal Research Inc., formed to fight a deadly type of brain cancer, is being recognized this week by the Association of Public and Land-Grant Universities and the Association of American Universities.
Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of brain cancer recently diagnosed in U.S. Sen. John McCain.
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it isn’t hypothetical – the researchers were recently awarded a grant from the Commonwealth Research Commercialization Fund, part of the Center for Innovative Technology, to engineer a viral therapy.